Grégori Gerebtzoff - Concepedia

Author

Grégori Gerebtzoff

Novartis (Switzerland)ORCID

Also Known As

Gerebtzoff, Grégori, Grégori Gerebtzoff

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Novartis (Switzerland)Novartis Institutes for BioMedical Research University of Basel Roche (Switzerland)

About

Grégori Gerebtzoff is an author at Novartis (Switzerland) specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	385
2	Engineering	2	2	28
3	Biostatistics	2	2	28
4	Natural Sciences	1	1	279
5	Biochemistry	1	1	279

Grégori Gerebtzoff

Publications

614

Citations

H-Index

Page 1

	Year	Citations
Halogenation of Drugs Enhances Membrane Binding and Permeation Grégori Gerebtzoff, Xiaochun Li‐Blatter, Holger Fischer, ChemBioChem Pharmaceutical ScienceBiochemistryMedicineMembrane TransportLipid Membrane	2004	279
In Silico Prediction of Blood−Brain Barrier Permeation Using the Calculated Molecular Cross-Sectional Area as Main Parameter Grégori Gerebtzoff, Anna Seelig Journal of Chemical Information and Modeling	2006	78
Safety screening in early drug discovery: An optimized assay panel Stefanie Bendels, Caterina Bissantz, Bernhard Fasching, Journal of Pharmacological and Toxicological Methods Drug SafetyPredictive ToxicologyPreclinical Drug EvaluationBioanalysisPharmacology	2019	78
Systematic Evaluation of Local and Global Machine Learning Models for the Prediction of ADME Properties Elena Di Lascio, Grégori Gerebtzoff, Raquel Rodríguez-Pérez Molecular Pharmaceutics	2023	37
Application of machine learning models for property prediction to targeted protein degraders Giulia Peteani, Minh Huynh, Grégori Gerebtzoff, Nature Communications	2024	36
Multispecies Machine Learning Predictions of In Vitro Intrinsic Clearance with Uncertainty Quantification Analyses Raquel Rodríguez-Pérez, Markus Trunzer, Nadine Schneider, Molecular Pharmaceutics	2022	34
Design and synthesis of novel imidazo[1,2-a]quinoxalines as PDE4 inhibitors Carine Deleuze‐Masquéfa, Grégori Gerebtzoff, Guy Subra, Bioorganic & Medicinal Chemistry	2004	32
Identification of bile salt export pump inhibitors using machine learning: Predictive safety from an industry perspective Raquel Rodríguez-Pérez, Grégori Gerebtzoff Artificial Intelligence in the Life Sciences EngineeringMachine LearningQuantitative PharmacologyDiagnosisSystem Pharmacology	2021	14
Adapting Deep Learning QSPR Models to Specific Drug Discovery Projects Andrin Fluetsch, Elena Di Lascio, Grégori Gerebtzoff, Molecular Pharmaceutics Drug TargetEngineeringMachine LearningHit IdentificationDrug Resistance	2024	14
Deep Learning Models Compared to Experimental Variability for the Prediction of CYP3A4 Time-Dependent Inhibition Andrin Fluetsch, Markus Trunzer, Grégori Gerebtzoff, Chemical Research in Toxicology	2024	12

Page 1